Zobrazeno 1 - 10
of 30
pro vyhledávání: '"T J, Schnitzer"'
Autor:
F, Eckstein, R J, Buck, D, Burstein, H C, Charles, J, Crim, M, Hudelmaier, D J, Hunter, G, Hutchins, C, Jackson, V Byers, Kraus, N E, Lane, T M, Link, L S, Majumdar, S, Mazzuca, P V, Prasad, T J, Schnitzer, M S, Taljanovic, A, Vaz, B, Wyman, M-P Hellio, Le Graverand, Kenneth, Brandt
Publikováno v:
Annals of the Rheumatic Diseases. 67:1683-1688
Quantitative MRI (qMRI) of cartilage morphology is a promising tool for disease-modifying osteoarthritis drug (DMOAD) development. Recent studies at single sites have indicated that measurements at 3.0 Tesla (T) are more reproducible (precise) than t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::73dcbf75f1dfd61873a4804f8bfe41b3
https://doi.org/10.1136/ard.2007.076919
https://doi.org/10.1136/ard.2007.076919
Autor:
R, Rizzoli, S L, Greenspan, G, Bone, T J, Schnitzer, N B, Watts, S, Adami, A J, Foldes, C, Roux, M A, Levine, B, Uebelhart, A C, Santora, A, Kaur, C A, Peverly, J J, Orloff
Publikováno v:
Journal of Bone and Mineral Research. 17:1988-1996
The aim of this study was to provide confirmation that once-weekly dosing with 70 mg of alendronate (seven times the daily oral dose) and twice-weekly dosing with 35 mg is equivalent to the 10-mg once-daily regimen and to gain more extensive safety e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::76b1a99d0f7610b50e4ab05f58636d1f
https://doi.org/10.1359/jbmr.2002.17.11.1988
https://doi.org/10.1359/jbmr.2002.17.11.1988
Publikováno v:
Journal of clinical rheumatology : practical reports on rheumaticmusculoskeletal diseases. 1(5)
In a randomized, single-blind, 28-day study, a new high strength capsaicin cream (0.25%) applied twice daily (n = 31) was compared with four-times-daily application of low strength capsaicin cream (0.025%; n = 29) for the treatment of pain associated
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::fc4e7d79506d11ee0ffcf1918f9e26ac
https://pubmed.ncbi.nlm.nih.gov/19077996
https://pubmed.ncbi.nlm.nih.gov/19077996
Publikováno v:
The Journal of rheumatology. 28(12)
Osteoarthritis (OA) clinical studies generally employ various endpoints to evaluate a spectrum of disease manifestations. Compared with individual endpoints, a composite measure might (1) provide a uniform outcome measure of OA efficacy with greater
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::0d89215dd409eef7feeff528c3a1000d
https://pubmed.ncbi.nlm.nih.gov/11764220
https://pubmed.ncbi.nlm.nih.gov/11764220
Autor:
T J, Schnitzer
Publikováno v:
Medscape women's health. 6(5)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::76d4c91867ac9bb5a43c598c092e335d
https://pubmed.ncbi.nlm.nih.gov/11698930
https://pubmed.ncbi.nlm.nih.gov/11698930
Publikováno v:
Arthritis and rheumatism. 43(5)
The rate of progressive joint space narrowing in the contralateral hip after total hip arthroplasty (THA) for osteoarthritis (OA) and the factors which may predispose patients to more aggressive joint space narrowing remain undefined. The current stu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::83fec12fc5541c4b652070132e8c1524
https://pubmed.ncbi.nlm.nih.gov/10817550
https://pubmed.ncbi.nlm.nih.gov/10817550
Publikováno v:
The Journal of rheumatology. 27(3)
To evaluate the efficacy and safety of tramadol in the treatment of chronic low back pain.A 3 phase trial: (1) a washout/screening phase; (2) a 3 week, open label, run-in phase; and (3) a 4 week, randomized, placebo controlled, double blind treatment
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::cd3c4260355bf66e6cce0d418b160c91
https://pubmed.ncbi.nlm.nih.gov/11128691
https://pubmed.ncbi.nlm.nih.gov/11128691
Autor:
D E, Yocum, S, Allard, S B, Cohen, P, Emery, R M, Flipo, J, Goobar, S, Jayawardena, C, Job-Deslandre, R W, Jubb, K, Krüger, A, Lopes Vaz, B, Manger, E, Mur, H, Nygaard, S M, Weiner, F, Rainer, M R, Sack, M H, Schiff, T J, Schnitzer, L B, Trigg, I, Whatmough, A G, Schmidt
Publikováno v:
Rheumatology (Oxford, England). 39(2)
To compare the safety, tolerability and efficacy of the new oral microemulsion formulation of cyclosporin A (CyA; Sandimmun Neoral) and the original CyA formulation (Sandimmun), in patients with severe active rheumatoid arthritis (RA), over a 12-mont
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::5c3583159db68b9d401e24c8d777f868
https://pubmed.ncbi.nlm.nih.gov/10725065
https://pubmed.ncbi.nlm.nih.gov/10725065
Autor:
T J, Schnitzer, K, Truitt, R, Fleischmann, P, Dalgin, J, Block, Q, Zeng, J, Bolognese, B, Seidenberg, E W, Ehrich
Publikováno v:
Clinical therapeutics. 21(10)
Nonsteroidal anti-inflammatory drugs. (NSAIDs) inhibit both cyclooxygenase (COX)-1 and COX-2 isoenzymes and are effective in the treatment of inflammatory disorders. This 8-week, double-masked, placebo-controlled trial was undertaken to assess the sa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::6f0b35837bde24d8b923d5d5c382ae6e
https://pubmed.ncbi.nlm.nih.gov/10566565
https://pubmed.ncbi.nlm.nih.gov/10566565
Autor:
E W, Ehrich, T J, Schnitzer, H, McIlwain, R, Levy, F, Wolfe, M, Weisman, Q, Zeng, B, Morrison, J, Bolognese, B, Seidenberg, B J, Gertz
Publikováno v:
The Journal of rheumatology. 26(11)
To determine the efficacy and safety of the cyclooxygenase 2 (COX-2) specific inhibitor, rofecoxib in patients with osteoarthritis (OA) of the knee.Rofecoxib, 25 mg or 125 mg once daily, was compared with placebo in a 6 week, double blind, parallel g
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::8a2e1af72271b888fb066a1d36c993e2
https://pubmed.ncbi.nlm.nih.gov/10555907
https://pubmed.ncbi.nlm.nih.gov/10555907